We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
+18.5%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.93B
AUM Growth
+$31.2M
Cap. Flow
+$169M
Cap. Flow %
8.75%
Top 10 Hldgs %
45.68%
Holding
151
New
31
Increased
40
Reduced
42
Closed
31

Top Buys

Rank Stock Value
1
ENSG icon
The Ensign Group
ENSG
+$104M
2
EHC icon
Encompass Health
EHC
+$86.2M
3
CTRE icon
CareTrust REIT
CTRE
+$42.1M
4
UNH icon
UnitedHealth
UNH
+$19M
5
INSM icon
Insmed
INSM
+$18.1M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$68.9M
2
NTRA icon
Natera
NTRA
+$44.5M
3
DOC icon
Healthpeak Properties
DOC
+$32.5M
4
AVTR icon
Avantor
AVTR
+$23.3M
5
QGEN icon
Qiagen
QGEN
+$20.3M

Sector Composition

Rank Sector Weight
1 Healthcare 89.53%
2 Real Estate 5.59%
3 Miscellaneous 4.84%
4 Financials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DAWN
126
DELISTED
Day One Biopharmaceuticals
DAWN
– –
-183,902
Closed -$3.94M
DHC
127
Diversified Healthcare Trust
DHC
$1.82B
– –
-151,283
Closed -$1M
DOC icon
128
Healthpeak Properties
DOC
$14.2B
– –
-1,981,070
Closed -$32.5M
EHAB
129
DELISTED
Enhabit
EHAB
– –
-227,451
Closed -$3.2M
ESPR
130
DELISTED
Esperion Therapeutics
ESPR
– –
-1,735,963
Closed -$4.76M
HQY icon
131
HealthEquity
HQY
$7.95B
– –
-51,614
Closed -$4.31M
HYG icon
132
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.4B
– –
-180,000
Closed -$14.3M
ICLR icon
133
Icon
ICLR
$12.7B
– –
-68,688
Closed -$7.6M
IMCR icon
134
Immunocore
IMCR
$1.86B
– –
-39,238
Closed -$1.18M
INMD icon
135
InMode
INMD
$858M
– –
-67,744
Closed -$927K
IWM icon
136
PUT
iShares Russell 2000 ETF
IWM
$80.5B
– –
-40,000
Closed -$9.92M
KPTI icon
137
CALL
Karyopharm Therapeutics
KPTI
$40.6M
– –
-23,800
Closed -$133K
MDGL icon
138
Madrigal Pharmaceuticals
MDGL
$12.5B
– –
-10,000
Closed -$5.23M
NVCR icon
139
NovoCure
NVCR
$2.09B
– –
-134,917
Closed -$1.47M
PASG icon
140
Passage Bio
PASG
$15M
– –
-131,581
Closed -$1.03M
PRAX icon
141
PUT
Praxis Precision Medicines
PRAX
$9.82B
– –
-14,800
Closed -$4.77M
QGEN icon
142
Qiagen
QGEN
$8.98B
– –
-545,330
Closed -$20.3M
REPL icon
143
CALL
Replimune Group
REPL
$1.42B
– –
-52,000
Closed -$398K
SPY icon
144
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$814B
– –
-107,000
Closed -$69.6M
STRO icon
145
Sutro Biopharma
STRO
$333M
– –
-73,161
Closed -$1.82M
TLT icon
146
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$47.1B
– –
-428,800
Closed -$37.2M
TYRA icon
147
Tyra Biosciences
TYRA
$1.71B
– –
-27,055
Closed -$1.04M
UNH icon
148
CALL
UnitedHealth
UNH
$356B
– –
-40,000
Closed -$10.8M
VRTX icon
149
CALL
Vertex Pharmaceuticals
VRTX
$138B
– –
-90,000
Closed -$40.2M
XLE icon
150
CALL
State Street Energy Select Sector SPDR ETF
XLE
$42.2B
– –
-50,000
Closed -$3.06M
3 4 5
6
7

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
GIA
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.94B AUM 32.92% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

Eversept Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Eversept Partners held 151 positions worth $1.93B, up 1.6% from $1.9B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Eversept Partners deployed $169M of net new capital in Q2 2026, opening 31 new positions and adding to 40 existing holdings. Its largest new stake was CareTrust REIT: 1,072,015 shares worth $43.3M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 74% a quarter earlier, followed by Real Estate and Miscellaneous.

On the sell side, the largest reduction was GSK, an estimated $68.9M trimmed.

  • Eversept Partners's largest Q2 2026 buy was CareTrust REIT: 1,072,015 shares worth $43.3M.
  • Eversept Partners added most to The Ensign Group in Q2 2026, an estimated $104M increase.
  • Eversept Partners's biggest Q2 2026 reduction was GSK, cutting an estimated $68.9M.
  • Eversept Partners fully exited Healthpeak Properties in Q2 2026, selling an estimated $32.5M.
  • Eversept Partners's ten largest holdings make up 46% of its $1.93B portfolio in Q2 2026.
  • Eversept Partners opened 31 new positions and closed 31 in Q2 2026.
  • Eversept Partners's portfolio value rose 1.6% quarter-over-quarter to $1.93B.

Based on Eversept Partners's 13F filing for Q2 2026, filed 14 Aug 2026.